The DOI matches its Crossref record; 244 of the 244 references it cites were found in a registry or an index.
Mitochondrial function as a therapeutic target in heart failure
Open accessAbstract
The pathophysiology of heart failure is complex, but mitochondrial dysfunction is an emerging therapeutic target to improve cardiac function. In this Consensus Statement, insights into the mechanisms of mitochondrial dysfunction in heart failure are presented, along with an overview of emerging treatments with the potential to improve the function of the failing heart by targeting mitochondria. Heart failure is a pressing worldwide public-health problem with millions of patients having worsening heart failure. Despite all the available therapies, the condition carries a very poor prognosis. Existing therapies provide symptomatic and clinical benefit, but do not fully address molecular abnormalities that occur in cardiomyocytes. This shortcoming is particularly important given that most patients with heart failure have viable dysfunctional myocardium, in which an improvement or normalization of function might be possible. Although the pathophysiology of heart failure is complex, mitochondrial dysfunction seems to be an important target for therapy to improve cardiac function directly. Mitochondrial abnormalities include impaired mitochondrial electron transport chain activity, increased formation of reactive oxygen species, shifted metabolic substrate utilization, aberrant mitochondrial dynamics, and altered ion homeostasis. In this Consensus Statement, insights into the mechanisms of mitochondrial dysfunction in heart failure are presented, along with an overview of emerging treatments with the potential to improve the function of the failing heart by targeting mitochondria.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–244 of 244
Primeßnig, U., Schönleitner, P., Höll, A., Pfeiffer, S., Bracic, T., Rau, T., Kapl, M., Stojaković, T., Glasnov, T. N., Leineweber, K., et al. (2016) · European Journal of Heart Failure · doi:10.1002/ejhf.524 · Cited by 70
Self-citationGhaffari, S., Kazemi, B., Toluey, M., & Sepehrvand, N. (2012) · Cardiovascular Therapeutics · doi:10.1111/1755-5922.12010 · Cited by 68
“Targeting the Heart” in Heart Failure
Wilcox, J. E., Fonarow, G. C., Ardehali, H., Bonow, R. O., Butler, J., Sauer, A. J., Epstein, S. E., Khan, S. S., Kim, R. J., Sabbah, H. N., et al. (2015) · JACC Heart Failure · doi:10.1016/j.jchf.2015.04.011 · Cited by 67
Self-citationJavadov, S. A., Jang, S., Rodriguez, N., Rodríguez‐Zayas, A. E., Hernández, J. S., Krainz, T., Wipf, P., & Frontera, W. R. (2015) · Oncotarget · doi:10.18632/oncotarget.5783 · Cited by 67
Ketones Step to the Plate: A Game Changer for Metabolic Remodeling in Heart Failure?
Kolwicz, S. C., Airhart, S. E., & Tian, R. (2016) · Circulation · doi:10.1161/circulationaha.116.021230 · Cited by 67
Mitochondrial Autophagy: An Essential Quality Control Mechanism for Myocardial Homeostasis
Thomas, R. L., & Gustafsson, Å. B. (2013) · Circulation Journal · doi:10.1253/circj.cj-13-0835 · Cited by 66
Neubauer, S., Horn, M., Pabst, T., Harre, K., Strömer, H., Bertsch, G., Sandstede, J., Ertl, G., Hahn, D., & KOCHSIEK, K. (1997) · Journal of Investigative Medicine · doi:10.1177/108155899704500810 · Cited by 66
Greenberg, B., Chou, W., Saikali, K. G., Escandon, R. D., Lee, J. H., Chen, M. M., Treshkur, T., Megreladze, I., Wasserman, S. M., Eisenberg, P. R., et al. (2014) · JACC Heart Failure · doi:10.1016/j.jchf.2014.07.009 · Cited by 65
Developing New Treatments for Heart Failure: Focus on the Heart
Gheorghiade, M., Larson, C. J., Shah, S. J., Greene, S. J., Cleland, J. G. F., Colucci, W. S., Dunnmon, P. M., Epstein, S. E., Kim, R. J., Parsey, R. V., et al. (2016) · Circulation Heart Failure · doi:10.1161/circheartfailure.115.002727 · Cited by 65
Self-citationTherapeutic potential of resveratrol in heart failure
Sung, M. M. Y., & Dyck, J. R. B. (2015) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12839 · Cited by 63
Dramatic improvement in mitochondrial cardiomyopathy following treatment with idebenone
Lerman‐Sagie, T., Rustin, P., Lev, D., et al. (2001) · Journal of Inherited Metabolic Disease · doi:10.1023/a:1005642302316 · Cited by 62
Shi, J., Dai, W., Hale, S. L., Brown, D. A., Wang, M., Han, X., & Kloner, R. A. (2015) · Life Sciences · doi:10.1016/j.lfs.2015.09.022 · Cited by 62
Self-citationBakkehaug, J. P., Kildal, A. B., Engstad, E. T., Boardman, N., Næsheim, T., Rønning, L., Aasum, E., Larsen, T. S., Myrmel, T., & How, O.-J. (2015) · Circulation Heart Failure · doi:10.1161/circheartfailure.114.002152 · Cited by 62
Lyamzaev, K. G., Pustovidko, A. V., Simonyan, R. A., Rokitskaya, T. I., Domnina, L. V., Ivanova, O. Y., Severina, I. I., Sumbatyan, N. V., Korshunova, G. A., Tashlitsky, V. N., et al. (2011) · Pharmaceutical Research · doi:10.1007/s11095-011-0504-8 · Cited by 61
Role of microRNA in metabolic shift during heart failure
Pinti, M. V., Hathaway, Q. A., & Hollander, J. M. (2016) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00341.2016 · Cited by 59
Perspectives in innate and acquired cardioprotection: cardioprotection acquired through exercise
Brown, D. A., & Moore, R. L. (2007) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00464.2007 · Cited by 57
Self-citationMolecular and Cellular Basis of Viable Dysfunctional Myocardium
Bayeva, M., Sawicki, K. T., Butler, J., Gheorghiade, M., & Ardehali, H. (2014) · Circulation Heart Failure · doi:10.1161/circheartfailure.113.000912 · Cited by 57
Self-citationBrown, D. A., Sabbah, H. N., & Shaikh, S. R. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.07.005 · Cited by 56
Self-citationKoyama, H., Nojiri, H., Kawakami, S., Sunagawa, T., Shirasawa, T., & Shimizu, T. (2013) · Molecules · doi:10.3390/molecules18021383 · Cited by 52
Goikoetxea, M. J., Beaumont, J., González, A., López, B., Querejeta, R., Larman, M., & Dı́ez, J. (2005) · Cardiovascular Research · doi:10.1016/j.cardiores.2005.11.016 · Cited by 51
Mamidi, R., Gresham, K. S., Li, A. S., dos Remedios, C. G., & Stelzer, J. E. (2015) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2015.06.011 · Cited by 50
Eirin, A., Williams, B. J., Ebrahimi, B., Zhang, X., Crane, J. A., Lerman, A., Textor, S. C., & Lerman, L. O. (2013) · Journal of Hypertension · doi:10.1097/hjh.0b013e3283658a53 · Cited by 50
Enhancing the metabolic substrate: PPAR-alpha agonists in heart failure
Sarma, S., Ardehali, H., & Gheorghiade, M. (2010) · Heart Failure Reviews · doi:10.1007/s10741-010-9208-0 · Cited by 49
Self-citationMITOCARE Study Group (2012) · Cardiology · doi:10.1159/000342981 · Cited by 49
Dysregulation of cardiolipin biosynthesis in pediatric heart failure
Chatfield, K. C., Sparagna, G. C., Sucharov, C. C., Miyamoto, S. D., Grudis, J. E., Sobus, R. D., Hijmans, J. G., & Stauffer, B. L. (2014) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2014.06.002 · Cited by 48
Self-citationSchaefer, S., Schwartz, G. G., Steinman, S., Meyerhoff, D. J., Massie, B. M., & Weiner, M. W. (1992) · Magnetic Resonance in Medicine · doi:10.1002/mrm.1910250205 · Cited by 48
Sharov, V. G., Todor, A. V., Imai, M., et al. (2005) · Heart Failure Reviews · doi:10.1007/s10741-005-7545-1 · Cited by 47
Abozguia, K., Phan, T. T., Shivu, G. N., Maher, A. R., Ahmed, I., Wagenmakers, A. J. M., & Frenneaux, M. P. (2008) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2008.05.009 · Cited by 44
Treatment of Mitochondrial Disorders: Antioxidants and Beyond
Enns, G. M. (2014) · Journal of Child Neurology · doi:10.1177/0883073814538509 · Cited by 43
Antioxidant, EUK-8, Prevents Murine Dilated Cardiomyopathy
Kawakami, S., Matsuda, A., Sunagawa, T., Noda, Y., Kaneko, T., Tahara, S., Hiraumi, Y., Adachi, S., Matsui, H., Ando, K., et al. (2009) · Circulation Journal · doi:10.1253/circj.cj-09-0204 · Cited by 42
Contemporary Drug Development in Heart Failure: Call for Hemodynamically Neutral Therapies
Vaduganathan, M., Butler, J., Pitt, B., & Gheorghiade, M. (2015) · Circulation: Heart Failure · doi:10.1161/circheartfailure.115.002271 · Cited by 38
Self-citationEsposito, A., COBELLI, F. D., Perseghin, G., Pieroni, M., Belloni, E., Mellone, R., Canu, T., Gentinetta, F., Scifo, P., Chimenti, C., et al. (2008) · Heart · doi:10.1136/hrt.2008.142562 · Cited by 36
Nicolau, S. M., de Diego, A. M. G., Cortés, L., Egea, J., Gonzalez, J., Mosquera, M., López, M. G., Hernández-Guijo, J. M., & de Diego, A. M. G. (2009) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.154765 · Cited by 35
Malonyl CoA: A promising target for the treatment of cardiac disease
Fillmore, N., & Lopaschuk, G. D. (2014) · IUBMB Life · doi:10.1002/iub.1253 · Cited by 30
Nagasaka, S., Katoh, H., Niu, C. F., Matsui, S., Urushida, T., Satoh, H., Watanabe, Y., & Hayashi, H. (2007) · Circulation Journal · doi:10.1253/circj.71.429 · Cited by 30
Hiemstra, J. A., Gutiérrez‐Aguilar, M., Marshall, K. D., McCommis, K. S., Zgoda, P. J., Cruz-Rivera, N., Jenkins, N. T., Krenz, M., Domeier, T. L., Baines, C. P., et al. (2014) · Physiological Reports · doi:10.14814/phy2.12050 · Cited by 28
Zhang, Q., Hu, L., Yin, C.-S., Chen, P., Li, H.-Q., Sun, X., & Yan, G. (2014) · Inflammation Research · doi:10.1007/s00011-014-0734-4 · Cited by 27
Mattila, M., Koskenvuo, J. W., Söderström, M., Eerola, K., & Savontaus, M. (2016) · The Journal of Gene Medicine · doi:10.1002/jgm.2885 · Cited by 23
Igarashi, N., Nozawa, T., Fujii, N., Suzuki, T., Matsuki, A., Nakadate, T., Igawa, A., & Inoue, H. (2006) · Circulation Journal · doi:10.1253/circj.70.1509 · Cited by 21
Effect of N-2-mercaptopropionyl glycine on exercise-induced cardiac adaptations
Nelson, M. J., Harris, M. B., Boluyt, M. O., Hwang, H. S., & Starnes, J. W. (2011) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00405.2010 · Cited by 20
Heart Failure at the Crossroads: Moving Beyond Blaming Stakeholders to Targeting the Heart
Senni, M., Gavazzi, A., Gheorghiade, M., & Butler, J. (2015) · European Journal of Heart Failure · doi:10.1002/ejhf.315 · Cited by 18
Self-citationMenon, B., Krishnamurthy, P., Kaverina, E., Johnson, J. N., Ross, R. S., Singh, M., & Singh, K. (2006) · Basic Research in Cardiology · doi:10.1007/s00395-006-0602-7 · Cited by 17
Léger, B., Koopman, R., Walrand, S., Gehrig, S. M., Murphy, K. T., & Lynch, G. S. (2010) · International Journal of Cardiology · doi:10.1016/j.ijcard.2010.10.078 · Cited by 14
Cardiac Myosin Activators in Systolic Heart Failure: More Friend than Foe?
Moin, D. S., Sackheim, J., HAMO, C. E., & Butler, J. (2016) · Current Cardiology Reports · doi:10.1007/s11886-016-0778-x · Cited by 8
Self-citation
Cited by
Mitochondrial dysfunction: mechanisms and advances in therapy
Zong, Y., Li, H., Liao, P., Chen, L., Pan, Y., Zheng, Y., Zhang, C., Liu, D., Zheng, M., & Gao, J. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01839-8 · Cited by 1,172
Mitochondrial dysfunction in pathophysiology of heart failure
Zhou, B., & Tian, R. (2018) · Journal of Clinical Investigation · doi:10.1172/jci120849 · Cited by 923
Mitochondria as a therapeutic target for common pathologies
Murphy, M. P., & Hartley, R. C. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.174 · Cited by 827
Ischemia/Reperfusion Injury Revisited: An Overview of the Latest Pharmacological Strategies
Soares, R. O. S., Losada, D. M., Jordani, M. C., Évora, P., & Castro-e-Silva, O. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20205034 · Cited by 408
The pyruvate-lactate axis modulates cardiac hypertrophy and heart failure
Cluntun, A. A., Badolia, R., Lettlova, S., Parnell, K. M., Shankar, T. S., Diakos, N. A., Olson, K. A., Taleb, I., Tatum, S. M., Berg, J. A., et al. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2020.12.003 · Cited by 345
Metadata
- Authors
- Brown, D. A., Perry, J. B., Allen, M. E., Sabbah, H. N., Stauffer, B. L., Shaikh, S. R., Cleland, J. G. F., Colucci, W. S., Butler, J., Voors, A. A., Anker, S. D., Pitt, B., Pieske, B., Filippatos, G., Greene, S. J., & Gheorghiade, M.
- Venue
- Nature Reviews Cardiology
- Published
- 2016-12-22
- Volume
- 14
- Issue
- 4
- Pages
- 238-250
- ISSN
- 1759-5002 (ISSN-L)
- 1759-5010
- OpenAlex
- W2565443325
- Cited by
- 803
- References
- 244
- FWCI
- 3.63
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.